PTX:ASX
Prescient Therapeutics Ltd
A$0.065
arrow_downward
-4.41%(-0.0030) 1D
Sep 8, 4:10:29 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
66.40M
Avg. vol.
918.06K
Volume
1.08M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.06
Mkt. cap
66.40M
Avg. vol.
918.06K
Volume
1.08M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
News stories
From web sources and news partners
Kalkine Media
·
54 minutes ago
Prescient Therapeutics (ASX:PTX) Extends Share Purchase Plan Deadline to 15 September 2026
TipRanks
·
7 hours ago
Prescient Therapeutics Extends Securities Purchase Plan Deadline
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com